Literature DB >> 19401964

[Hilar cholangiocarcinoma (Klatskin's tumor): up-to-date radiologic diagnosis, intervention and treatment possibilities].

J P Goltz1, W Kenn, D Hahn, C O Ritter.   

Abstract

HISTORY AND ADMISSION
FINDINGS: A 53-year-old man with jaundice was referred with suspected cholangiocarcinoma of the porta hepatis. He was found to be in a reduced general and nutritional condition. Cholinesterase was decreased, total bilirubin, GOT, GPT and alkaline phosphatase were increased. INVESTIGATIONS: Abdominal contrast-enhanced computed tomography revealed a centrally located and contrast-enhancing mass at the proximal common hepatic duct. Metastases were not detectable. Endoscopic retrograde cholangiography showed a stenosis of the proximal common hepatic duct. An additional magnetic resonance tomography with cholangio-pancreatography confirmed the centrally located tumor as well as the stenosis of the common hepatic duct. DIAGNOSIS, TREATMENT AND COURSE: The diagnostic tests were suggestive of a stage IV cholangiocarcinoma of the porta hepatis (Klatskin's tumor). The origin was subsequently proven histologically. There was no evidence of intra- or extrahepatic metastases. An interventional embolization of the right portal vein was performed preoperatively to stimulate the growth of the left hepatic lobe. But before surgery could take place a percutaneous transhepatic cholangiography and biliary drainage had to be done followed by an extended right-sided hemihepatectomy. During a 12 month follow-up no recurrence was observed.
CONCLUSION: Klatskin's tumor is rare and requires interdisciplinary collaboration. Recent developments in diagnostic, interventional and surgical methods result in a better prognosis.

Entities:  

Mesh:

Year:  2009        PMID: 19401964     DOI: 10.1055/s-0029-1222555

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  1 in total

1.  The multimodal treatment of central and peripheral cholangiocarcinoma - analysis based on a single center experience.

Authors:  Horatiu Ciprian Neagos; Florin Graur; Otilia Elena Neagos; Dinu Iuliu Dumitrascu; Florin Mihaileanu; Liviu Vlad
Journal:  Clujul Med       Date:  2015-04-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.